Trainings and Resources
26 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Apply now to HRSA’s Graduate Psychology Education (GPE) program to receive funding for training doctoral health psychology students, interns, and post-doctoral residents in behavioral health and substance use disorder prevention and treatment services. Through the GPE program, HRSA aims to prepare and increase the mental and behavioral health workforce to address the opioid crisis in high-need areas of the country. The program also supports faculty development of health service psychology. Learn more about eligibility, funding, and the period of performance on HRSA’s GPE Program page.
Posted 9/8/2021 (updated 10/1/2021)
Jordana Latozas ACNP, President of Recovery Mobile Clinic, described the mobile medical model and discuss how they are growing and developing in the field Learning Objectives: Recognize the current scope of Mobile units focused on Addiction medicine Recognize the lack of rural area SUD and MAT treatment Identify difficulties with the Mobile Model Identify Ways to bring the Mobile Model into mainstream SUD/OUD treatment Presenter: Jordana Latozas ACNP, President of Recovery Mobile Clinic
Posted 8/25/2021 (updated 9/2/2021)
Created by the Association of State and Provincial Psychology Boards (ASPPB), the Psychology Interjurisdictional Compact (PSYPACT) is an interstate compact that facilitates the practice of psychology using telecommunications technologies (telepsychology) and/or temporary in-person, face-to-face psychological practice.
Posted 8/11/2021 (updated 9/2/2021)
Now in its 32nd year, Recovery Month celebrates the gains made by those in recovery, just as we celebrate improvements made by those who are managing other health conditions such as hypertension, diabetes, asthma, and heart disease. Each September, Recovery Month works to promote and support new evidence-based treatment and recovery practices, the emergence of a strong and proud recovery community, and the dedication of service providers and community members across the nation who make recovery in all its forms possible.
Posted 5/17/2021 (updated 9/2/2021)
New medications for office-based treatment of opioid addiction are comparable in efficacy to other chronic conditions such as diabetes, asthma, and hypertension when combined with other interventions and as part of a comprehensive care plan. They are safe, highly effective, can be prescribed and/or administered at the Community Health Center, with a sustainable business plan.
Posted 4/26/2021 (updated 9/2/2021)
A Protocol Using Empirically Supported Behavioral Treatments for People with Psychoactive Stimulant Use Disorders
Posted 3/17/2021 (updated 9/2/2021)
NADCP, in partnership with the Office of National Drug Control Policy, Executive Office of the President, is proud to share the redesigned Annals of Research and Knowledge (ARK)! The ARK is a searchable online database of evidence-based and promising programs that allows professionals to search for programs designed for justice-involved people at all stages. Each program is accompanied by relevant research and tools for application in your jurisdiction. Looking for a program to fit a specific population in your community? The ARK is your first stop!
Posted 3/5/2021 (updated 9/2/2021)
The Blueprints for Healthy Youth Development mission is to provide a comprehensive registry of scientifically proven and scalable interventions that prevent or reduce the likelihood of antisocial behavior and promote a healthy course of youth development and adult maturity. We also advocate for evidence-based interventions locally and nationally and produce publications on the importance of adopting high-scientific standards when evaluating what works in social and crime prevention interventions.
Posted 2/18/2021 (updated 9/2/2021)
Opioid use disorder (OUD), a chronic disease, is a major public health problem. Despite availability of effective treatment, too few people receive it and treatment retention is low. Understanding barriers and facilitators of treatment access and retention is needed to improve outcomes for people with OUD. In this study we sought to assess 3-month outcomes from a patient-centered practice that included MAT with buprenorphine or naltrexone plus the option to participate in psychosocial treatments. The psychosocial treatments included case management, psychotherapy, peer recovery groups such as Narcotics Anonymous or Smart Recovery, or peer support through a local harm reduction program.
Posted 2/24/2021 (updated 9/2/2021)
This webinar provided new information on the risks and clinical challenges presented by individuals who use psychostimulants (cocaine, methamphetamine and prescription stimulants). A review of the clinical strategies that are important in working with this population were presented, including psychosocial and medication treatments for those with stimulant use disorder. Presented by Richard Rawson, Ph.D.